JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Year-over-year operating income growth rate
Latest
-28.66%
↓ 154% vs avg
Percentile
P23
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
-11.29%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -28.66% |
| Q3 2025 | -65.78% |
| Q2 2025 | 65.33% |
| Q1 2025 | -39.14% |
| Q4 2024 | 8.53% |
| Q3 2024 | 2.61% |
| Q2 2024 | 56.51% |
| Q1 2024 | -29.55% |
| Q4 2023 | -5.33% |
| Q3 2023 | 13.89% |
| Q2 2023 | 43.74% |
| Q1 2023 | -28.70% |
| Q4 2022 | -12.94% |
| Q3 2022 | 8.64% |
| Q2 2022 | -6.36% |
| Q1 2022 | 11.58% |
| Q4 2021 | -27.70% |
| Q3 2021 | -4.99% |
| Q2 2021 | -3.18% |
| Q1 2021 | -4.08% |
| Q4 2020 | -5.86% |
| Q3 2020 | 35.43% |
| Q2 2020 | 85.54% |
| Q1 2020 | -61.40% |
| Q4 2019 | 4.03% |
| Q3 2019 | 4.33% |
| Q2 2019 | -30.48% |
| Q1 2019 | 34.50% |
| Q4 2018 | 9.01% |
| Q3 2018 | 8.78% |
| Q2 2018 | -35.83% |
| Q1 2018 | 54.31% |
| Q4 2017 | 31.25% |
| Q3 2017 | -1.65% |
| Q2 2017 | 169.40% |
| Q1 2017 | -417.99% |
| Q4 2016 | -3.41% |
| Q3 2016 | -9.55% |
| Q2 2016 | 140.22% |
| Q1 2016 | -416.71% |